[1] Castelo Branco C, Garcia Fantini M, Haya J. Vascular reactivity and atheromatous plaques in post-menopausal women on tibolone treatment. Open prospective study with Doppler ultrasonography in internal carotid artery. [J]. Maturitas: International Journal for the Study of the Climacteric 2005, 4(4).
[2] Bots ML, Evans GW, Riley W. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness:the Osteoporosis Prevention and Arterial effects of tibolone(OPAL)study [J]. EUROPEAN HEART JOURNAL 2006, 27(06).
[3] Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, Ouyang P, Thompson P, Tardif JC, Higginson L, Bittner V, Steffes M, Gordon DJ, Proschan M, Younes N, Verter JI. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. [J]. JAMA: the Journal of the American Medical Association 2002, 19(19).
[4] Sanjuan A, Castelo Branco C, Colodron M, Ascaso C, Vicente JJ, Ordi J, Casals E, Mercade I, Escaramis G, Vanrell JA. Effects of estradiol, cyproterone acetate, tibolone and raloxifene on uterus and aorta atherosclerosis in oophorectomized cholesterol-fed rabbits. [J]. Maturitas: International Journal for the Study of the Climacteric 2003, 1(1).
[5] Maffei S, Mereuri A, Zucchelli GC. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women [J]. International Journal of Cardiology 2006, 107(02).
[6] Topcuoglu A, Uzun H, Aydin S, Kahraman N, Vehid S, Zeybek G, Topcuoglu D. The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women. [J]. The Tohoku Journal of Experimental Medicine 2005, 1(1). |
